Reforming and Enhancing the European R&I System
Similar to the free movement of goods and services, the European Commission wants to expand the European Research area in which researchers and innovators can move around in the EU without encountering legal, technological or physical borders. The primary objective is thus to stimulate the mobility of people active in R&I and diffuse the available knowledge all over Europe.
Your NCP contact for this programme
Margot Beereboom
margot.beereboom@fwo.be
+32 2 550 15 76
About this programme
During the new programme period, the European Research Area (ERA) will support a new phase in the development of the ERA and synergies with the European Higher Education Area, which may include a stronger focus on supporting the challenges identified in Pillar II, including missions and partnerships, to ensure that the strategic investments made there deliver maximum impact.
Opening the European Research Area to future challenges requires developing synergies with the European Higher Education Area in a complex landscape of universities and research organisations with a view to underpinning open science, innovative entrepreneurial practices, life-long-learning and upskilling talent and breaking down disciplinary and inter-sectoral barriers to match emerging business and societal needs.
Impacts will include better alignment of national reforms and increased programme level collaboration across Member States and Associated Countries, and will help increase the impact of both national and European investments in research and innovation. This will also support other research and innovation priorities including Open Science, citizens’ science, gender equality and other forms of diversity, improving international cooperation, ethics and integrity, and scientific input to other EU policies.
Latest news
Enhancing EU R&I Horizon Europe
EU Award for Gender Equality Champions third edition open for submissions
The EU Award for Gender Equality Champions was created under Horizon Europe to recognise the results achieved by academic and research organisations in the implementation of gender equality plans (GEPs). GEPs is an eligibility criterion for all public bodies, higher education institutions and research organisations from EU Member States and associa... read more
MSCA RI Health Culture and society
Horizon Europe Impact training session and Proposal workshop coming up this...
Interested in strengthening your skills to develop a strong project proposal in the framework of the Horizon Europe programme? Mark the following events, co-organised by NCP Flanders, in your agenda: - Learn more about how to plan for impact in your project proposal during the ‘Impact in Horizon Europe’ training session on 15 October 20... read more
Upcoming events
RI Health Culture and society Security Digital, Industry & Space
Impact in Horizon Europe - training session: Registration open
ERC Culture and society Security Digital, Industry & Space Agro-Food, Environment
SEREN5 Online Training “Horizon Europe Security Appraisal Process”
Enhancing EU R&I HorizonEU L+F
European IP Helpdesk webinar: IP & Open Science
Widening/Spreading Enhancing EU R&I Horizon Europe
Panel discussion: The European Framework Programme for Research and Innovat...
Work Programme & Calls
Infosheets
Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.
Related links
Related links are easy pointers towards external information. We curate the list, but are not liable for the destinations.
- EREA Open Science in Horizon Europe
- NCP_WIDERA.NET fact sheet ERA call 2024
- Showcase of citizen science by ERC grantees and other EU-funded projects
- Citizen Science and Frontier Research: ERC Annual Event 2022
- NCP_WIDERA.NET factsheet ERA call 2023
- NCP_WIDERA.NET Policy Brief ERA Policy Agenda
- Citizen science in ERC projects
- COM Info Day WIDERA 23-24 Work Programme
- Citizen Science projects - Cordis Results Pack
- History of Changes - Widening participation and strengthening the ERA Work Programme 2021-2022
- EC DG Research & Innovation Open Science
- Citizen science factsheet
- ERA Forum for Transition
- EC DG Research & Innovation ERA
- European Research Executive Agency - HE Reforming and enhancing the European R&I system
- Recorded video and presentations 21.04.2021 - HEU open science, gender, dissemination&exploitation, do not significant harm principle
- EC DG Research and Innovation - Gender equality in R&I
- Gender equality Horizon Europe factsheet
- ERC gender projects - Cordis Results Pack
- European Open Science Cloud
Documents
Documents contain additional information related to this programme, and are similar to related links.
- Zero-tolerance code of conduct. Counteracting gender-based violence, including sexual harassment, in the EU research and innovation system
- Report on good practices from European University Alliances Projects (pilot II)
- Report on Research Assessment
- Researchers’ skills: analysis of progress made in projects funded under Horizon 2020 and Horizon Europe, including the European University Alliances
- Report on COVID-19 impact on gender equality in research and innovation
- Report on approaches to inclusive gender equality in research and innovation
- Study to evaluate the ERA policy framework and ERA monitoring mechanism
- Gender Dimension in Horizon Europe proposals
Testimonial
BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
